{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T01:47:25Z","timestamp":1789091245929,"version":"build-2803163510"},"reference-count":15,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,5,16]],"date-time":"2024-05-16T00:00:00Z","timestamp":1715817600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100013072","name":"Major Science and Technology Project of Hainan Province","doi-asserted-by":"publisher","award":["ZDKJ2019009"],"award-info":[{"award-number":["ZDKJ2019009"]}],"id":[{"id":"10.13039\/501100013072","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Global Antimicrobial Resistance"],"published-print":{"date-parts":[[2024,9]]},"DOI":"10.1016\/j.jgar.2024.05.005","type":"journal-article","created":{"date-parts":[[2024,5,21]],"date-time":"2024-05-21T07:02:26Z","timestamp":1716274946000},"page":"1-5","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"special_numbering":"C","title":["Sepsis and pneumonia caused by Enterococcus faecium following liver transplantation treated with contezolid as the first-line therapy"],"prefix":"10.1016","volume":"38","author":[{"given":"Xiangyan","family":"Liu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhuoyi","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weilin","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shusen","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jgar.2024.05.005_bib0001","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1128\/CMR.10.1.86","article-title":"Infections in solid organ transplant recipients","volume":"10","author":"Patel","year":"1997","journal-title":"Clin Microbiol Rev"},{"key":"10.1016\/j.jgar.2024.05.005_bib0002","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1007\/s15010-007-7123-7","article-title":"Enterococcal-associated lower respiratory tract infections: a case report and literature review","volume":"37","author":"Grupper","year":"2009","journal-title":"Infection"},{"key":"10.1016\/j.jgar.2024.05.005_bib0003","doi-asserted-by":"crossref","first-page":"837","DOI":"10.12669\/pjms.293.2925","article-title":"Efficacy of linezolid on gram-positive bacterial infection in elderly patients and the risk factors associated with thrombocytopenia","volume":"29","author":"Bi","year":"2013","journal-title":"Pak J Med Sci"},{"key":"10.1016\/j.jgar.2024.05.005_bib0004","article-title":"In vitro activity of contezolid against methicillin-resistant Staphylococcus aureus, vancomycin-resistant Enterococcus, and strains with linezolid resistance genes from China","volume":"12","author":"Wang","year":"2021","journal-title":"Front Microbiol"},{"key":"10.1016\/j.jgar.2024.05.005_bib0005","doi-asserted-by":"crossref","first-page":"1762","DOI":"10.1093\/jac\/dkac073","article-title":"A phase III multicentre, randomized, double-blind trial to evaluate the efficacy and safety of oral contezolid versus linezolid in adults with complicated skin and soft tissue infections","volume":"77","author":"Zhao","year":"2022","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.jgar.2024.05.005_bib0006","doi-asserted-by":"crossref","first-page":"1435","DOI":"10.1161\/CIR.0000000000000296","article-title":"Infective endocarditis in adults: diagnosis, antimicrobial therapy, and management of complications: a scientific statement for healthcare professionals from the American Heart Association","volume":"132","author":"Baddour","year":"2015","journal-title":"Circulation"},{"key":"10.1016\/j.jgar.2024.05.005_bib0007","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1016\/j.hbpd.2021.03.009","article-title":"Vancomycin-induced acute kidney injury after liver transplantation","volume":"20","author":"Shi","year":"2021","journal-title":"Hepatob Pancreat Dis Int"},{"key":"10.1016\/j.jgar.2024.05.005_bib0008","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1007\/s00134-009-1738-3","article-title":"The Surviving Sepsis Campaign: results of an international guideline-based performance improvement program targeting severe sepsis","volume":"36","author":"Levy","year":"2010","journal-title":"Intensive Care Med"},{"key":"10.1016\/j.jgar.2024.05.005_bib0009","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1186\/s12941-020-00354-2","article-title":"The risk of vancomycin toxicity in patients with liver impairment","volume":"19","author":"Brunetti","year":"2020","journal-title":"Ann Clin Microbiol Antimicrob"},{"key":"10.1016\/j.jgar.2024.05.005_bib0010","first-page":"1050","article-title":"Clinical efficacies of linezolid and teicoplanin in sequential treatment of severe pneumonia caused by gram-positive cocci","volume":"25","author":"Dong-Sheng","year":"2015","journal-title":"Chin J Nosocomiol"},{"key":"10.1016\/j.jgar.2024.05.005_bib0011","doi-asserted-by":"crossref","first-page":"e01195","DOI":"10.1128\/AAC.01195-20","article-title":"In vitro activity and potency of the novel oxazolidinone contezolid (MRX-I) tested against gram-positive clinical isolates from the United States and Europe","volume":"64","author":"Carvalhaes","year":"2020","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.jgar.2024.05.005_bib0012","doi-asserted-by":"crossref","first-page":"1195","DOI":"10.1517\/13543784.8.8.1195","article-title":"Mechanism of action of the oxazolidinone antibacterial agents","volume":"8","author":"Shinabarger","year":"1999","journal-title":"Expert Opin Investig Drugs"},{"key":"10.1016\/j.jgar.2024.05.005_bib0013","doi-asserted-by":"crossref","first-page":"1736","DOI":"10.1093\/cid\/ciab699","article-title":"Proposed linezolid dosing strategies to minimize adverse events for treatment of extensively drug-resistant tuberculosis","volume":"74","author":"Imperial","year":"2022","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jgar.2024.05.005_bib0014","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1016\/j.jiac.2016.05.003","article-title":"A retrospective study of the risk factors for linezolid-induced thrombocytopenia and anemia","volume":"22","author":"Hanai","year":"2016","journal-title":"J Infect Chemother"},{"key":"10.1016\/j.jgar.2024.05.005_bib0015","doi-asserted-by":"crossref","first-page":"4487","DOI":"10.1021\/jm401931e","article-title":"New potent antibacterial oxazolidinone (MRX-I) with an improved class safety profile","volume":"57","author":"Gordeev","year":"2014","journal-title":"J Med Chem"}],"container-title":["Journal of Global Antimicrobial Resistance"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213716524000936?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213716524000936?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,9,15]],"date-time":"2024-09-15T09:41:20Z","timestamp":1726393280000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213716524000936"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9]]},"references-count":15,"alternative-id":["S2213716524000936"],"URL":"https:\/\/doi.org\/10.1016\/j.jgar.2024.05.005","relation":{},"ISSN":["2213-7165"],"issn-type":[{"value":"2213-7165","type":"print"}],"subject":[],"published":{"date-parts":[[2024,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Sepsis and pneumonia caused by Enterococcus faecium following liver transplantation treated with contezolid as the first-line therapy","name":"articletitle","label":"Article Title"},{"value":"Journal of Global Antimicrobial Resistance","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jgar.2024.05.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier Ltd on behalf of International Society for Antimicrobial Chemotherapy.","name":"copyright","label":"Copyright"}]}}